Publication | Open Access

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

Lymphoid NeoplasiaCancer ImmunosurveillanceAutoimmune DiseaseAnti-pd-1 Antibody-based RegimensImmunologyHematologyPathologyImmune Checkpoint InhibitorAutoimmunityImmunotherapyMedicine